Medtronic probed by US finance committee over GPO contract cancellation
This article was originally published in Clinica
Executive Summary
The chairman of the US Senate Finance Committee Max Baucus has launched an investigation into Medtronic's recent cancellations of its contracts with the country's top two group purchasing organisations (GPOs), Novation and Premier. The inquiry seeks to find out if the actions by the world's largest pure-play medtech company could reduce price transparency in the healthcare system and increase costs for patients.